<DOC>
	<DOCNO>NCT00168857</DOCNO>
	<brief_summary>A number blood pressure lower drug class know angiotensin receptor blocker ( ARB ) show slow decline kidney function patient type 2 diabetes , high blood pressure , kidney disease . Losartan ( COZAAR ) , one drug . The purpose research study determine one year treatment telmisartan ( MICARDIS , GLIOSARTAN , KINZAL , KINZALMONO , PREDXAL , PRITOR , SAMERTAN , TELMISARTAN ) 80 mg , another blood pressure lower drug ARB class , effective losartan ( COZAAR ) 100 mg reduce level urinary protein ( indicative improve kidney function ) .</brief_summary>
	<brief_title>A Prospective , Randomised , Double-blind , Double-dummy , Forced-titration , Multicentre , Parallel Group , One Year Treatment Trial Compare Telmisartan ( MICARDIS ) 80 mg Versus Losartan ( COZAAR ) 100 mg , Hypertensive Type 2 Diabetic Patients With Overt Nephropathy ( AMADEO Study )</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria />
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>